Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2)

Area of Science:

• * Molecular biology and immunology
• * Infectious disease research

Background:

• * Chlamydia pneumoniae is a significant respiratory pathogen.
• * Developing effective vaccines against C. pneumoniae is crucial for public health.

Purpose of the Study:

• * To evaluate the immunogenicity and protective efficacy of DNA vaccines encoding C. pneumoniae MOMP, Omp2, and Hsp60.
• * To assess the impact of these vaccines on bacterial load, antibody response, and lung pathology.

Main Methods:

• * BALB/c mice were intramuscularly vaccinated three times with DNA plasmids encoding MOMP, Omp2, or Hsp60.
• * Mice were challenged intranasally with C. pneumoniae.
• * Lung bacterial counts, serum antibody levels, and histological lung sections were analyzed.

Main Results:

• * Vaccination with MOMP or Hsp60 DNA vaccines resulted in a 1.2-1.5 log reduction in lung bacterial counts.
• * Specific antibodies were detected in mice vaccinated with Omp2 or Hsp60 DNA vaccines.
• * No vaccine significantly reduced the severity of pneumonia, but all induced higher lymphoid reactions in the lungs.

Conclusions:

• * DNA vaccines encoding C. pneumoniae MOMP and Hsp60 demonstrate partial efficacy in reducing bacterial load.
• * While antibody responses were observed, complete protection against infection and pneumonia was not achieved.
• * The vaccines induced immunological memory in the lungs, suggesting potential for future vaccine development.